PRIMARY-HF: Heart Failure Screening in Primary Care Using Point-of- Care
NCT: NCT07711821 · RECRUITING
Brief Summary
The goal of this clinical trial is to evaluate whether the use of NT-proBNP testing and point-of-care ultrasound (POCUS) can improve the diagnosis and management of heart failure in adults aged 50 years or older with suspected heart failure or cardiovascular risk factors in primary care settings. The main questions it aims to answer are: * Does the use of NT-proBNP and/or POCUS increase the rate of new heart failure diagnoses compared with standard care? * Does this approach support earlier initiation of guideline-directed medical therapy and improve patients' quality of life? Researchers will compare standard care alone with standard care combined with NT-proBNP testing, POCUS, or both, to assess their impact on diagnosis and management of heart failure. Participants will: * Be randomly assigned to one of four groups (standard care, NT-proBNP, POCUS, or both). * Undergo clinical evaluation for heart failure according to their assigned group. * Be followed for 12 months with periodic assessments of quality of life and treatment adherence.
Frequently Asked Questions
What is PRIMARY-HF: Heart Failure Screening in Primary Care Using Point-of- Care?
PRIMARY-HF: Heart Failure Screening in Primary Care Using Point-of- Care is a clinical trial registered under NCT07711821. Current status: RECRUITING.
What is the status of NCT07711821?
The current status of NCT07711821 (PRIMARY-HF: Heart Failure Screening in Primary Care Using Point-of- Care) is: RECRUITING.
When did PRIMARY-HF: Heart Failure Screening in Primary Care Using Point-of- Care start?
PRIMARY-HF: Heart Failure Screening in Primary Care Using Point-of- Care started on 2026-03-23.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.